D. Kasper

发表

A microbial symbiosis factor prevents intestinal inflammatory disease

S. Mazmanian, J. Round, D. Kasper, 2008, Nature.

Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen

H. Tettelin, R. Rappuoli, D. Kasper, 2005, Science.

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

D. Kasper, F. Avci, Xiangming Li, 2011, Nature Medicine.

An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System

S. Mazmanian, D. Kasper, C. Liu, 2005, Cell.

Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome".

Jaideep P. Sundaram, Christopher R. Hauser, Samuel V. Angiuoli, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Immunologic response of man to group B meningococcal polysaccharide vaccines.

D. Kasper, D L Kasper, M. Artenstein, 1972, The Journal of infectious diseases.

Structure, conformation and immunology of sialic acid-containing polysaccharides of human pathogenic bacteria

D. Kasper, R. Roy, F. Michon, 1984 .

Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine

D. Kasper, M. Wessels, L. Paoletti, 1992, Infection and immunity.

Vitamin and trace Mineral Deficiency and Excess

J. Loscalzo, A. Fauci, D. Kasper, 2008 .

Structural features of polysaccharides that induce intra-abdominal abscesses.

D. Kasper, A. Tzianabos, A. Onderdonk, 1993, Science.

Novel Engagement of CD14 and Multiple Toll-Like Receptors by Group B Streptococci1

V. Nizet, S. Akira, D. Kasper, 2001, The Journal of Immunology.

4,8-anhydro-N-acetylneuraminic acid. Isolation from edible bird's nest and structure determination.

D. Kasper, H. Jennings, V. Pozsgay, 1987, European journal of biochemistry.

Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis.

D. Kasper, A. Tzianabos, A. Onderdonk, 1998, Journal of immunology.

Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

J. Bartlett, D. Kasper, A. Onderdonk, 1977, The Journal of infectious diseases.

Modulation of surgical fibrosis by microbial zwitterionic polysaccharides.

D. Kasper, A. Sharpe, M. Sayegh, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Isolation and Chemical Characterization of a Capsular Polysaccharide Antigen Shared by Clinical Isolates ofEnterococcus faecalis and Vancomycin-ResistantEnterococcus faecium

Y. Wang, D. Kasper, D. Goldmann, 1999, Infection and Immunity.

Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae

D. Kasper, R. Finberg, M. Chan, 1994, Infection and immunity.

Interactions Cells by MHC Class II-Dependent Zwitterionic Polysaccharides Stimulate T

H. Ploegh, D. Kasper, A. Tzianabos, 2002 .

Zwitterionic Polysaccharides Stimulate T Cells by MHC Class II-Dependent Interactions1

H. Ploegh, D. Kasper, A. Tzianabos, 2002, The Journal of Immunology.

Cellular Immunity Zwitterionic Polysaccharides to Stimulate Effect of Molecular Size on the Ability of

Y. Wang, D. Kasper, A. Tzianabos, 1999 .

Glycoconjugate vaccines to prevent group B streptococcal infections

D. Kasper, L. Paoletti, 2003, Expert opinion on biological therapy.

Intraperitoneal host cellular responses and in vivo killing of Bacteroides fragilis in a bacterial containment chamber

D. Kasper, R. Finberg, A. Onderdonk, 1989, Infection and immunity.

Structure of the complex group-specific polysaccharide of group B Streptococcus.

D. Kasper, F. Michon, H. Jennings, 1987, Biochemistry.

Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein

D. Kasper, L. Madoff, J. Michel, 1992, Infection and immunity.

Inactivation of the α C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus

F. Ausubel, D. Kasper, B. Rosner, 1997 .

Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus.

F. Ausubel, D. Kasper, B. Rosner, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Animal model system for studying virulence of and host response to Bacteroides fragilis.

D. Kasper, R. Finberg, A. Onderdonk, 1990, Reviews of infectious diseases.

The changing spectrum of group B streptococcal disease.

D. Kasper, M. Wessels, M. R. Wessels, 1993, The New England journal of medicine.

Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis.

D. Kasper, Dennis L. Kasper, 1976, The Journal of infectious diseases.

A novel mechanism for glycoconjugate vaccine activation of the adaptive immune system

D. Kasper, F. Avci, Xiangming Li, 2012 .

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

D. Kasper, F. Avci, Xiangming Li, 2011, Nature Medicine.

What is it? Case 4, 1986.

D. Kasper, R. Scully, 1986, Movement disorders : official journal of the Movement Disorder Society.

Quantitative determination of antibodies to type III group B streptococcal polysaccharide.

D. Kasper, L. Paoletti, C. Baker, 1996, The Journal of infectious diseases.

Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines

D. Kasper, L. Paoletti, C. Baker, 2001, Infection and Immunity.

Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.

D. Kasper, M. Wessels, L. Paoletti, 1999, The Journal of infectious diseases.

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

D. Kasper, C. Baker, 1976, The New England journal of medicine.

Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.

D. Kasper, L. Paoletti, C. Baker, 2004, The Journal of infectious diseases.

Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.

D. Kasper, C. Baker, M. Edwards, 1981, Pediatrics.

Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.

D. Kasper, L. Paoletti, C. Baker, 2000, The Journal of infectious diseases.

Microbial carbohydrate depolymerization by antigen-presenting cells: Deamination prior to presentation by the MHCII pathway

D. Kasper, F. Avci, J. Duan, 2008, Proceedings of the National Academy of Sciences.

Cognate Stimulatory B-Cell–T-Cell Interactions Are Critical for T-Cell Help Recruited by Glycoconjugate Vaccines

D. Kasper, A. Sharpe, A. Chandraker, 1999, Infection and Immunity.

Isolation of carbohydrate-specific CD4+ T cell clones from mice after stimulation by two model glycoconjugate vaccines

D. Kasper, F. Avci, Xiangming Li, 2012, Nature Protocols.

Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine

D. Kasper, M. Wessels, L. Paoletti, 1993, Infection and immunity.

Effect of B7-2 and CD40 Signals from Activated Antigen-Presenting Cells on the Ability of Zwitterionic Polysaccharides To Induce T-Cell Stimulation

D. Kasper, A. Tzianabos, T. Stephen, 2005, Infection and Immunity.

Zwitterionic Polysaccharides Stimulate T Cells with No Preferential Vβ Usage and Promote Anergy, Resulting in Protection against Experimental Abscess Formation1

D. Kasper, A. Tzianabos, S. Porcelli, 2004, The Journal of Immunology.

IL-17-Dependent Mechanism Intra-abdominal Sepsis by an T Cells Mediate Abscess Formation in + CD 4

D. Kasper, M. Sayegh, A. Tzianabos, 2003 .

CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism 1

D. Kasper, M. Sayegh, A. Tzianabos, 2003, The Journal of Immunology.

Biological chemistry of immunomodulation by zwitterionic polysaccharides.

D. Kasper, Julia Y. Wang, A. Tzianabos, 2003, Carbohydrate research.

Role of T cells in abscess formation.

D. Kasper, A. Tzianabos, 2002, Current opinion in microbiology.

Structure-function relationships for polysaccharide-induced intra-abdominal abscesses

D. Kasper, A. Tzianabos, A. Onderdonk, 1994, Infection and immunity.

Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis.

D. Kasper, A. Tzianabos, A. Onderdonk, 1995, The Journal of clinical investigation.

Bacteroides fragilis subspecies in clinical isolates.

B. Polk, D. Kasper, 1977, Annals of internal medicine.

Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.

J. Bartlett, D. Kasper, A. Onderdonk, 1979, The Journal of infectious diseases.

Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: differential stimulatory effect on mouse and rat lymphocytes in vitro.

D. Kasper, A. Tzianabos, R. Finberg, 1999, Journal of immunology.

Structural characteristics of polysaccharides that induce protection against intra-abdominal abscess formation

D. Kasper, A. Tzianabos, A. Onderdonk, 1994, Infection and immunity.

Isolation and identification of encapsulated strains of Bacteroides fragilis.

B. Polk, D. Kasper, A. Onderdonk, 1977, The Journal of infectious diseases.

Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.

T. Tosteson, D. Kasper, M. Wessels, 1992, The Journal of clinical investigation.

Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis

D. Kasper, A. Pantosti, A. Tzianabos, 1991, Infection and immunity.

Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy.

J. Brisson, D. Kasper, A. Tzianabos, 1992, Biochemistry.

Maternal antibody at delivery protects neonates from early onset group B streptococcal disease.

R. Platt, D. Kasper, S. Hillier, 2014, The Journal of infectious diseases.

Structural and Genetic Diversity of Group B Streptococcus Capsular Polysaccharides

Gustavo Glusman, J. Fahey, Stephanie D Rodrigues, 2005, Infection and Immunity.

Surface Structures of Group BStreptococcusImportant in Human Immunity

D. Kasper, L. Paoletti, 2019, Gram-Positive Pathogens.

Surface Structures of Group B Streptococcus Important in Human Immunity

D. Kasper, L. Paoletti, 2019, Microbiology spectrum.

Neonatal mouse model of group B streptococcal infection.

D. Kasper, A. Onderdonk, H. Warren, 1992, The Journal of infectious diseases.

A maternal vaccine against group B Streptococcus: past, present, and future.

D. Kasper, F. Avci, V. Chen, 2013, Vaccine.

Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women.

D. Kasper, L. Madoff, L. Paoletti, 1999, The Journal of infectious diseases.

Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B Streptococcus

D. Kasper, R. Carpenter, C. Baker, 1988 .

Conjugate vaccines against group B Streptococcus types IV and VII.

D. Kasper, L. Paoletti, 2002, The Journal of infectious diseases.

Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

D. Kasper, M. Wessels, C. Rubens, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus.

D. Kasper, C. Baker, 1977, The Journal of infectious diseases.

Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching

K. Mansfield, D. Kasper, L. Paoletti, 2008, Proceedings of the National Academy of Sciences.

Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons

D. Kasper, R. Kennedy, L. Paoletti, 1996, Infection and immunity.

Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses.

D. Kasper, A. Tzianabos, A. Onderdonk, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

D. Kasper, K. Holme, M. Wessels, 1990, The Journal of clinical investigation.

Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.

D. Kasper, C. Baker, M. Edwards, 1979, The Journal of infectious diseases.

Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

D. Kasper, R. Baltimore, C. Baker, 1977, Journal of immunology.

Molecular analysis of two group B streptococcal virulence factors.

D. Kasper, M. Wessels, J. Weiser, 1990, Seminars in perinatology.

Isolation and characterization of type IV group B Streptococcus capsular polysaccharide

D. Kasper, M. Wessels, F. Michon, 1989, Infection and immunity.

A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci

D. Kasper, L. Madoff, J. Michel, 1991, Infection and immunity.

Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling.

D. Kasper, Julia Y. Wang, H. Guttormsen, 2003, Vaccine.

Structural Properties of Group B Streptococcal Type III Polysaccharide Conjugate Vaccines That Influence Immunogenicity and Efficacy

D. Kasper, M. Wessels, L. Paoletti, 1998, Infection and Immunity.

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.

D. Kasper, M. Wessels, L. Paoletti, 1996, The Journal of clinical investigation.

An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus.

D. Kasper, K. Holme, M. Wessels, 1990, The Journal of biological chemistry.

Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide

D. Kasper, M. Wessels, D. L. Kasper, 1989, The Journal of experimental medicine.

Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide.

D. Kasper, C. Lugowski, H. Jennings, 1981, Biochemistry.

Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III.

D. Kasper, L. Paoletti, C. Baker, 2003, The Journal of infectious diseases.

Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.

D. Kasper, C. Baker, H. Jennings, 2002, The Journal of infectious diseases.

Type III Group B Streptococcal Polysaccharide Induces Antibodies That Cross-React with Streptococcus pneumoniae Type 14

D. Kasper, L. Paoletti, M. Nahm, 2002, Infection and Immunity.

Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum.

D. Kasper, L. Madoff, C. Baker, 2002, The Journal of infectious diseases.

Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate.

D. Kasper, R. Kennedy, L. Paoletti, 2000, The Journal of infectious diseases.

Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.

D. Kasper, L. Paoletti, K. D. Johnson, 1999, The Journal of infectious diseases.

Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.

D. Kasper, M. Wessels, L. Paoletti, 1995, The Journal of infectious diseases.

Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine

D. Kasper, M. Wessels, L. Paoletti, 1994, Infection and immunity.

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.

D. Kasper, R. Carpenter, C. Baker, 1989, The New England journal of medicine.

Group B streptococcal vaccines.

D. Kasper, C. Baker, 1985, Reviews of infectious diseases.

Structure of native polysaccharide antigens of type Ia and type Ib group B Streptococcus.

D. Kasper, C. Lugowski, H. Jennings, 1983, Biochemistry.

Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus.

D. Kasper, C. Baker, W. Mccormack, 1977, The Journal of clinical investigation.

Characterization of the Linkage between the Type III Capsular Polysaccharide and the Bacterial Cell Wall of Group BStreptococcus *

D. Kasper, M. Wessels, T. Krick, 2000, The Journal of Biological Chemistry.

Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy.

J. Brisson, D. Kasper, C. von Hunolstein, 1995, Carbohydrate research.

Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen.

D. Kasper, M. Wessels, H. Jennings, 1987, The Journal of biological chemistry.

Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.

D. Kasper, M. Wessels, R. Roy, 1985, Journal of immunology.

Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.

D. Kasper, C. Baker, H. Jennings, 1983, The Journal of clinical investigation.

Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus.

D. Kasper, H. Jennings, E. Katzenellenbogen, 1983, The Journal of biological chemistry.

Electron microscopic definition of surface antigens of group B Streptococcus.

D. Kasper, C. Baker, 1979, Journal of Infectious Diseases.

Antibody responses in invasive group B streptococcal infection in adults.

D. Kasper, L. Harrison, M. Wessels, 1998, The Journal of infectious diseases.

NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives.

J. Brisson, D. Kasper, M. van der Zwan, 1997, Biochemistry.

Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein.

D. Kasper, L. Madoff, D. E. Kling, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Structural and Immunochemical Characterization of the Type VIII Group B Streptococcus Capsular Polysaccharide (*)

J. Brisson, D. Kasper, D. Uhrín, 1996, The Journal of Biological Chemistry.

Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine

D. Kasper, M. Wessels, F. Michon, 1994, Infection and immunity.

Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci.

F. Ausubel, D. Kasper, L. Madoff, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Phenotypic diversity in the alpha C protein of group B streptococci

D. Kasper, L. Madoff, C. Baker, 1991, Infection and immunity.

Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity

F. Ausubel, D. Kasper, L. Madoff, 1991, Infection and immunity.

The alpha-L-(1----2)-trirhamnopyranoside epitope on the group-specific polysaccharide of group B streptococci

A. Gamian, D. Kasper, R. Feldman, 1991, Infection and immunity.

Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharide.

J. Brisson, D. Kasper, M. Wessels, 1991, The Journal of biological chemistry.

Multiantennary group-specific polysaccharide of group B Streptococcus.

J. Brisson, D. Kasper, A. Dell, 1988, Biochemistry.

A model of high-affinity antibody binding to type III group B Streptococcus capsular polysaccharide.

D. Kasper, M. Wessels, A. Munoz, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

D. Kasper, C. Baker, M. Edwards, 1982, The Journal of clinical investigation.

Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants.

D. Kasper, C. Baker, D. Goroff, 1978, Journal of immunology.

Structure of the Type VI Group B Streptococcus Capsular Polysaccharide Determined by High Resolution NMR Spectroscopy

J. Brisson, D. Kasper, D. Uhrín, 1994 .

Structure of the capsular polysaccharide antigen of type IV group B Streptococcus

J. Brisson, D. Kasper, M. Wessels, 1989 .

Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.

D. Kasper, N. J. Levy, 1986, Journal of immunology.

Potentiation of virulence by group B streptococcal polysaccharides.

D. Kasper, C. Baker, A. Nicholson-Weller, 1984, The Journal of infectious diseases.

Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination.

Jianzhu Chen, D. Kasper, M. Carroll, 2009, Clinical immunology.

Impaired Antibody Response to Group B Streptococcal Type III Capsular Polysaccharide in C3- and Complement Receptor 2-Deficient Mice1

D. Kasper, M. Carroll, F. Lalani, 2003, The Journal of Immunology.

Mice Complement Receptor 2-Deficient Capsular Polysaccharide in C 3-and Group B Streptococcal Type III Impaired Antibody Response

D. Kasper, M. Carroll, F. Lalani, 2002 .

Receptor 2-Deficient Mice Polysaccharide in C 3-and Complement Streptococcal Type III Capsular Impaired Antibody Response to Group B

D. Kasper, M. Carroll, F. Lalani, 2002 .

Alpha C Protein as a Carrier for Type III Capsular Polysaccharide and as a Protective Protein in Group B Streptococcal Vaccines

D. Kasper, L. Madoff, L. Paoletti, 1999, Infection and Immunity.

GROUP B STREPTOCOCCAL VACCINES

D. Kasper, C. Baker, 1986 .

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.

D. Kasper, L. Madoff, L. Paoletti, 1994, The Journal of clinical investigation.

Group B Streptococcus Type III Glycoconjugate Vaccines

D. Kasper, M. Wessels, L. Paoletti, 1992 .

Influence of preimmunization antibody levels on the specificity of the immune response to related polysaccharide antigens.

D. Kasper, C. Baker, G. Schiffman, 1980, The New England journal of medicine.

A unique structural pattern shared by T-cell-activating and abscess-regulating zwitterionic polysaccharides.

D. Kasper, M. Roehrl, Julia Y. Wang, 2002, Biochemistry.

Therapeutic potential of human antisera to group B streptococcal glycoconjugate vaccines in neonatal mice.

D. Kasper, L. Paoletti, A. Rodewald, 1997, The Journal of infectious diseases.

Identification of sialic acid in polysaccharide antigens in group B Streptococcus

D. Kasper, C. Baker, 1976, Infection and immunity.

Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus.

D. Kasper, H. Jennings, K. Rosell, 1980, Canadian journal of biochemistry.

T cell regulation of Bacteroides fragilis-induced intraabdominal abscesses.

D. Kasper, R. Finberg, A. Onderdonk, 1990, Reviews of infectious diseases.

Immunogenicity and protective efficacy of the alpha C protein of group B streptococci are inversely related to the number of repeats

D. Kasper, L. Madoff, D. E. Kling, 1997, Infection and immunity.

Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus

D. Kasper, C. Baker, C. Davis, 1976, The Journal of experimental medicine.

Immunization with a single-repeat alpha C protein may prevent escape of lower repeat mutants of group B Streptococcus.

D. Kasper, L. Madoff, C. Gravekamp, 1997, Advances in experimental medicine and biology.

Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells.

D. Kasper, M. Baron, 2005, The Journal of clinical investigation.

Antibody to type III group B Streptococcus in the rhesus monkey.

B. Curfman, D. Kasper, J. Sever, 1983, American journal of obstetrics and gynecology.

Designer vaccines to prevent infections due to group B Streptococcus.

D. Kasper, 1995, Proceedings of the Association of American Physicians.

Measurement of Human Antibodies to Type III Group BStreptococcus

D. Kasper, M. Wessels, L. Paoletti, 1999, Infection and Immunity.

Bacterial capsule--old dogmas and new tricks.

D. Kasper, 1986, The Journal of infectious diseases.

A soluble suppressor T cell factor protects against experimental intraabdominal abscesses.

D. Kasper, R. Finberg, A. Onderdonk, 1985, The Journal of clinical investigation.

Mouse protection test for group B Streptococcus type III.

D. Kasper, R. Baltimore, J. Vecchitto, 1979, The Journal of infectious diseases.

Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection.

D. Kasper, P. Rice, 1977, The Journal of clinical investigation.

Microcapsule of type III strains of group B Streptococcus: production and morphology

D. Kasper, C. Baker, 1976, Infection and immunity.

Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.

D. Kasper, J. Winkelhake, M. Artenstein, 1973, Journal of immunology.

Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis.

D. Kasper, R. Finberg, A. Onderdonk, 1986, Journal of immunology.

Cellular immunity to Bacteroides fragilis capsular polysaccharide

D. Kasper, R. Finberg, A. Onderdonk, 1982, The Journal of experimental medicine.

The role of anaerobic bacteria in abscess formation.

D. Kasper, D. Zaleznik, 1982, Annual review of medicine.

Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.

D. Kasper, R. Markham, A. Onderdonk, 1982, The Journal of clinical investigation.

CHARACTERIZATION OF THE "NATIVE" TYPE III POLYSACCHARIDE OF GROUP B STREPTOCOCCUS*

D. Kasper, C. Baker, C. Davis, 1976 .

Case records of the Massachusetts General Hospital. Case 25-2005. A 40-year-old man with prolonged fever and weight loss.

D. Sahani, D. Kasper, J. Misdraji, 2005, The New England journal of medicine.

SAFETY AND IMMUNOGENICITY OF GROUP B STREPTOCOCCAL (GBS) POLYSACCHARIDE (PS) TYPES Ia AND Ib-TETANUS TOXOID (Ia-TT; Ib-TT) CONJUGATE VACCINES IN WOMEN.▴ 980

D. Kasper, L. Paoletti, C. Baker, 1996, Pediatric Research.

Lack of stimulation of isohemagglutinin antibodies by immunization with group B streptococcal (type III) vaccine.

D. Kasper, C. Baker, B. Webb, 1981, The Journal of pediatrics.

Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins.

D. Kasper, P. Rice, 1982, The Journal of clinical investigation.

Antibody to group B Streptococcus type III in human sera measured by a mouse protection test

D. Kasper, R. Baltimore, C. Baker, 1981, Infection and immunity.

Bacteroides fragilis Formation by Cellular Mechanism of Intraabdominal Abscess

F. C. Gibson, D. Kasper, A. Tzianabos, 1998 .

Structural elucidation of the capsular polysaccharide of Bacteroides fragilis strain 23745M1.

J. Brisson, D. Kasper, D. Uhrín, 1995, Carbohydrate research.

Bacteroides fragilis strains express multiple capsular polysaccharides

D. Kasper, A. Pantosti, A. Tzianabos, 1993, Journal of clinical microbiology.

Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.

D. Kasper, R. Finberg, A. Onderdonk, 1984, Reviews of infectious diseases.

Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization

A. Weintraub, D. Kasper, A. Lindberg, 1983, Journal of bacteriology.

Antigenic Specificity of Immune Cells

D. Kasper, 2022 .

The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.

D. Kasper, D. L. Kasper, 1976, The Journal of infectious diseases.

Bacteroides fragilis NCTC9343 Produces at Least Three Distinct Capsular Polysaccharides: Cloning, Characterization, and Reassignment of Polysaccharide B and C Biosynthesis Loci

D. Kasper, A. Tzianabos, L. Comstock, 2000, Infection and Immunity.

Molecular size affects antigenicity of type III, group B Streptococcus capsular polysaccharide.

D. Kasper, M. Wessels, 1985, Transactions of the Association of American Physicians.

Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.

D. Kasper, A. Onderdonk, D. Zaleznik, 1986, The Journal of infectious diseases.

Group A and group B streptococcal vaccine development. A round table presentation.

D. Kasper, J. Musser, J. Zabriskie, 1997, Advances in experimental medicine and biology.

Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae.

D. Kasper, I. Tager, S. Pelton, 1980, The Journal of pediatrics.

Bacterial structure and functional relation to abscess formation.

D. Kasper, A. Tzianabos, A. Onderdonk, 1994, Infectious agents and disease.

Variations of Bacteroides fragilis with in vitro passage: presence of an outer membrane-associated glycan and loss of capsular antigen.

D. Kasper, A. Onderdonk, B. Reinap, 1980, The Journal of infectious diseases.

The role of complement and antibody in opsonophagocytosis of type II group B streptococci.

D. Kasper, C. Baker, M. Edwards, 1986, The Journal of infectious diseases.

vaccine. by a polysaccharide-protein conjugate elicited polysaccharide of group B streptococci Functional activity of antibodies to the group B

D. Kasper, M. Wessels, F. Michon, 2013 .

Interstrain Variation of the Polysaccharide B Biosynthesis Locus of Bacteroides fragilis: Characterization of the Region from Strain 638R

D. Kasper, A. Tzianabos, L. Comstock, 1999, Journal of bacteriology.

from Strain 638 R : Characterization of the Region fragilis Bacteroides B Biosynthesis Locus of Interstrain Variation of the Polysaccharide

D. Kasper, A. Tzianabos, L. Comstock, 1999 .

Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators.

F. C. Gibson, D. Kasper, A. Tzianabos, 1998, The Journal of infectious diseases.

Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates

D. Kasper, A. Pantosti, A. Tzianabos, 1995, Journal of clinical microbiology.

Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.

D. Kasper, M. Klempner, G. Simon, 1982, The Journal of infectious diseases.

Adherence of Bacteroides fragilis in vivo

J. Bartlett, D. Kasper, A. Onderdonk, 1978, Infection and immunity.

Structure and serology of the native polysaccharide antigen of type Ia group B streptococcus.

D. Kasper, H. Jennings, K. Rosell, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1

D. Kasper, N. J. Levy, N. Levy, 1985, Infection and immunity.

TWO UNLINKED GENETIC LOCI INTERACT TO CONTROL THE HUMAN IMMUNE RESPONSE TO TYPE III GROUP B STREPTOCOCCAL ANTIGEN

D. Kasper, C. Baker, J. Pandey, 1984, Journal of immunogenetics.

Enzyme-linked immunosorbent assay for measurement of antibody to type III group B streptococci

D. Kasper, R. Polin, S. Douglas, 1982, Journal of clinical microbiology.

The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus.

D. Kasper, C. Baker, M. Yow, 1980, American journal of obstetrics and gynecology.

Group B streptococcal colonization and antibody status in lower socioeconomic parturient women.

D. Kasper, C. Baker, D. Fleming, 1979, American journal of obstetrics and gynecology.

Colonization with group B streptococci in girls under 16 years of age.

D. Kasper, C. Baker, M. Hammerschlag, 1977, Pediatrics.

RAPID DIAGNOSIS OF BACTEROIDES INFECTIONS BY INDIRECT IMMUNOFLUORESCENCE ASSAY OF CLINICAL SPECIMENS

D. Kasper, S. Tabaqchali, A. Fiddian, 1979, The Lancet.

Streptococcus Response to Group B Role of Lipoteichoic Acid in the Phagocyte

S. Akira, D. Kasper, O. Takeuchi, 2005 .

Comprar Harrison's Manual Of Medicine 19th Ed. | D. Kasper | 9780071828529 | MCGRAW HILL

J. Loscalzo, A. Fauci, D. Kasper, 2016 .

Immunochemical Characterization ofTwo Surface Polysaccharides ofBacteroides fragilis

D. Kasper, A. Onderdonk, 1991 .

SEROLOGICAL EVIDENCE FOR THE ROLE OF BACTEROIDES FRAGILIS AND ENTEROBACTERIACEAE IN THE PATHOGENESIS OF ACUTE PELVIC INFLAMMATORY DISEASE

D. Kasper, V. Valtonen, P. Mäkelä, 1981, The Lancet.

Quantitative determination of the serum antibody response to the capsular polysaccharide of Bacteroides fragilis subspecies fragilis in women with pelvic inflammatory disease.

K. Holmes, D. Kasper, D. Eschenbach, 1978, The Journal of infectious diseases.

Serum Antibody Response to Bacteroides fragilis in Women with Abscesses Follwing Hysterectomy

B. Polk, S. Schoenbaum, D. Kasper, 1980, Obstetrics and gynecology.

Response to Group B Streptococcus Role of Lipoteichoic Acid in the Phagocyte

S. Akira, T. Hartung, D. Kasper, 2013 .

StreptococcusResponse to Group B Role of Lipoteichoic Acid in the

S. Akira, T. Hartung, D. Kasper, 2009 .

Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.

D. Kasper, M. Wessels, C. Rubens, 1989, Proceedings of the National Academy of Sciences of the United States of America.

GroupB Streptococcus TypeIIPolysaccharide-Tetanus

D. Kasper, H. Jennings, Lawrence C. PAOLETrI, 1992 .

Group A streptococcus epidemiology and vaccine implications.

D. Kasper, R. Cohen-Poradosu, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Isolation and Characterization of a Native Cell Wall Complex from Neisseria meningitidis

D. Kasper, M. Artenstein, W. Zollinger, 1972, Infection and immunity.

Comparison of assays for antibody to group B Streptococcus, type III.

D. Kasper, C. Baker, K. Boyer, 1980, The Journal of infectious diseases.

Vaccination as a measure for prevention of neonatal GBS infection.

D. Kasper, C. Baker, 1985, Antibiotics and chemotherapy.

Bacterial Glycans: Key Mediators of Diverse Host Immune Responses

D. Kasper, L. Comstock, 2006, Cell.

Immunodeterminant specificity of human immunity to type III group B streptococcus

D. Kasper, R. Baltimore, C. Baker, 1979, The Journal of experimental medicine.

The cell envelope of the Legionnaires' disease bacterium. Morphologic and biochemical characteristics.

D. Kasper, S. Ito, B. Mansheim, 1979, Annals of internal medicine.

Surface antigens as virulence factors in infection with Bacteroides fragilis.

J. Bartlett, B. Polk, D. Kasper, 1979, Reviews of infectious diseases.

Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.

D. Kasper, Tae-Hyun Kim, Jessica T. Pinkham, 2012, The Journal of infectious diseases.

Regulation of Virulence by a Two-Component System in Group B Streptococcus

D. Kasper, M. Wessels, Shengmei Jiang, 2005, Journal of bacteriology.

Native Cell Wall Complex from Neisseria meningitidis

D. Kasper, M. Artenstein, W. Zollinger, 2003 .

Immunochemical characterization of the outer membrane complex of Bacteroides fragilis subspecies fragilis.

D. Kasper, M. Seiler, 1975, The Journal of infectious diseases.

Lipopolysaccharides from Bacteroides fragilis are mitogenic for spleen cells from endotoxin responder and nonresponder mice

K. Joiner, D. Kasper, K. McAdam, 1982, Infection and immunity.

Genetic Diversity of the Capsular Polysaccharide C Biosynthesis Region of Bacteroides fragilis

D. Kasper, A. Pantosti, L. Comstock, 2000, Infection and Immunity.

Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.

D. Kasper, J. Winkelhake, M. Artenstein, 1973, The Journal of infectious diseases.

The role of complement in opsonization of GBS.

D. Kasper, C. Baker, A. Nicholson-Weller, 1985, Antibiotics and chemotherapy.

Characterization of Bacteroides fragilis strains based on antigen-specific immunofluorescence.

A. Weintraub, D. Kasper, A. Lindberg, 1983, The Journal of infectious diseases.

Capsular and ‘O’ serotype determinants of Bacteroides fragilis

D. Kasper, S. Tabaqchali, P. Fiddian, 1982, Infection.

Experimental animal models for anaerobic infections.

J. Bartlett, D. Kasper, T. Louie, 1979, Reviews of infectious diseases.

Characterization of Serum Resistance of Neisseria gonorrhoeae

D. Kasper, 2022 .

Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis.

A. Weintraub, D. Kasper, A. Lindberg, 1984, Reviews of infectious diseases.

The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice.

D. Kasper, R. Markham, A. Nicholson-Weller, 1982, Journal of immunology.

Polysaccharide Processing and Presentation by the MHCII Pathway

D. Kasper, A. Tzianabos, B. Cobb, 2004, Cell.

Bactericidal Antibody Assay Using 14C-Labeled Neisseria meningitidis 1

D. Kasper, F. Wyle, 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Functional Analysis in Type Ia Group B Streptococcusof a Cluster of Genes Involved in Extracellular Polysaccharide Production by Diverse Species of Streptococci*

D. Kasper, M. Wessels, M. Cieslewicz, 2001, The Journal of Biological Chemistry.

Antibody-independent activation of C1 by type Ia group B streptococci.

D. Kasper, C. Baker, A. Nicholson-Weller, 1982, The Journal of infectious diseases.

A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2

D. Kasper, D. Golenbock, A. Tzianabos, 2006, The Journal of experimental medicine.

Inactivation of the a C protein antigen gene, bca, by a novel shuttleysuicide vector results in attenuation of virulence and immunity in group B Streptococcus (Streptococcus agalactiaeysurface antigensybacterial pathogenesisybacterial vaccines)

F. Ausubel, D. Kasper, B. Rosner, 1997 .

Effect of Molecular Size on the Ability of Zwitterionic Polysaccharides to Stimulate Cellular Immunity1

D. Kasper, A. Tzianabos, R. Finberg, 2000, The Journal of Immunology.

Group B streptococcus infection in mother and child.

D. Kasper, R. Haft, 1991, Hospital practice.

Isolation of a serogroup 1-specific antigen from Legionella pneumophila.

D. Kasper, C. Lugowski, H. Jennings, 1982, The Journal of infectious diseases.

Detection of anticapsular antibodies to Bacteroides asaccharolyticus in serum from rabbits and humans by use of an enzyme-linked immunosorbent assay.

D. Kasper, B. Mansheim, 1979, The Journal of infectious diseases.

Harrison's Infectious Diseases, 2/E

A. Fauci, D. Kasper, 2013 .

3-Deoxy-d-manno-octulosonic Acid (Kdo) Hydrolase Identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila*

D. Kasper, Tae-Hyun Kim, R. Ross, 2010, The Journal of Biological Chemistry.

Meningococcal infections. 3. Studies of group A polysaccharide vaccines.

D. Kasper, M. Artenstein, E. Tramont, 1971, Bulletin of the World Health Organization.

IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection.

D. Kasper, A. Tzianabos, R. McLoughlin, 2008, Journal of immunology.

Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs

D. Kasper, A. Onderdonk, J. Breeling, 1988, Infection and immunity.

CD4+ T Cells Regulate Surgical and Postinfectious Adhesion Formation

D. Kasper, T. Chitnis, M. Sayegh, 2002, The Journal of experimental medicine.

Extensive surface diversity of a commensal microorganism by multiple DNA inversions

Laurie E. Comstock, Katja G. Weinacht, D. Kasper, 2001, Nature.

A Novel Approach to N-Acetyl-neuraminic Acid-Containing Oligosaccharides. Synthesis of a Glycosyl Donor Derivative of α-N-Acetyl-D-neuraminyl- (2-6) -D-galactose

D. Kasper, H. Jennings, V. Pozsgay, 1987 .

Harrison's Infectious Diseases

A. Fauci, D. Kasper, T. R. Harrison, 2010 .

Affinity chromatography of anti-meningococcal antiserum.

D. Kasper, J. Winkelhake, 1972, Journal of immunology.

IFN-γ Regulated Chemokine Production Determines the Outcome of Staphylococcus aureus Infection1

D. Kasper, A. Tzianabos, R. McLoughlin, 2008, The Journal of Immunology.

Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.

D. Kasper, C. Baker, A. Nicholson-Weller, 1982, Journal of immunology.

The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.

J. Bartlett, D. Kasper, A. Onderdonk, 1977, The Journal of infectious diseases.

Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae

Ian T. Paulsen, Jonathan A. Eisen, Scott Peterson, 2002, Proceedings of the National Academy of Sciences of the United States of America.

A Possible Role of Bacterial Antigens in the Pathogenesis of Autoimmune Thyroid Disease

D. Kasper, S. Ingbar, G. Cushing, 1987 .

Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species.

D. Kasper, J. Duan, Jinyou Duan, 2011, Glycobiology.

Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica.

D. Kasper, S. Ingbar, S. Winblad, 1983, Science.

Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus.

D. Kasper, A. Onderdonk, B. Mansheim, 1978, Journal of immunology.

Microreview: Zwitterionic capsular polysaccharides: the new MHCII‐dependent antigens

D. Kasper, B. Cobb, 2005, Cellular microbiology.

Characterization of the O-antigen Polymerase (Wzy) of Francisella tularensis*

D. Kasper, Tae-Hyun Kim, Jessica T. Pinkham, 2010, The Journal of Biological Chemistry.

Coming of age: carbohydrates and immunity

D. Kasper, D. Kasper, B. Cobb, 2005, European journal of immunology.

The love–hate relationship between bacterial polysaccharides and the host immune system

S. Mazmanian, D. Kasper, 2006, Nature Reviews Immunology.

Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways1

M. Freeman, V. Nizet, S. Akira, 2002, The Journal of Immunology.

Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR.

D. Kasper, B. Cobb, 2008, Glycobiology.

Regulation of T cells by gut commensal microbiota

D. Kasper, J. Duan, Jinyou Duan, 2011, Current opinion in rheumatology.

Lymphocyte macrophage interactions in the response to surgical infections.

D. Kasper, N. Christou, J. Mannick, 1987, Archives of surgery.

The role of specific antibody in alternative complement pathway- mediated opsonophagocytosis of type III, group B Streptococcus

D. Kasper, C. Baker, A. Nicholson-Weller, 1980, The Journal of experimental medicine.

Bactericidal antibody in genital infection due to Neisseria gonorrhoeae.

D. Kasper, P. Rice, W. McCormick, 1977, The Journal of infectious diseases.

Edward H. Kass, 1917–1990

F. Speizer, D. Kasper, 1990 .

HARRISON'S PRINCIPLES OF INTERNAL MEDICINE, 13TH EDITION:

Anthony S. Fauci, Kurt J. Isselbacher, K. Isselbacher, 2004 .

A review. Lessons from an animal model of intra-abdominal sepsis.

J. Bartlett, D. Kasper, T. Louie, 1978, Archives of surgery.

Polysaccharide Biosynthesis Locus Required for Virulence of Bacteroides fragilis

D. Kasper, A. Tzianabos, L. Comstock, 2001, Infection and Immunity.

A Mechanism for Neurodegeneration Induced by Group B Streptococci through Activation of the TLR2/MyD88 Pathway in Microglia1

I. Bechmann, D. Kasper, J. Volpe, 2006, The Journal of Immunology.

Immunochemical characterization of surface antigens of Bacteroides melaninogenicus.

D. Kasper, A. Onderdonk, B. Mansheim, 1979, Reviews of infectious diseases.

Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.

D. Kasper, J. W. Conlan, Jessica T. Pinkham, 2009, Vaccine.

Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria.

D. Kasper, S. Dasgupta, 2010, Advances in immunology.

Regulation of surface architecture by symbiotic bacteria mediates host colonization

S. Mazmanian, D. Kasper, C. Liu, 2008, Proceedings of the National Academy of Sciences.

Small Molecule Control of Virulence Gene Expression in Francisella tularensis

D. Kasper, S. Dove, James C. Charity, 2009, PLoS pathogens.

Beneficial effects of Bacteroides fragilis polysaccharides on the immune system.

D. Kasper, E. Troy, 2010, Frontiers in bioscience.

IL-2 mediates protection against abscess formation in an experimental model of sepsis.

D. Kasper, A. Tzianabos, R. Finberg, 1999, Journal of immunology.

Independent Signaling Pathways Differentiation Factor 88-Dependent and Streptococcus Involve Parallel Myeloid Bactericidal Activity Against Group B Cellular Activation , Phagocytosis , and

M. Freeman, V. Nizet, S. Akira, 2002 .

Tetanus toxoid stimulation of the hypothalamic-pituitary-adrenal axis correlates inversely with the increase in tetanus toxoid antibody titers.

D. Kasper, R. Gleason, G. Adler, 1998, The Journal of clinical endocrinology and metabolism.

Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus1

Osamu Takeuchi, Douglas T. Golenbock, Thomas Hartung, 2005, The Journal of Immunology.

Immunologic Memory Induced by a Glycoconjugate Vaccine in a Murine Adoptive Lymphocyte Transfer Model

D. Kasper, R. Finberg, L. Wetzler, 1998, Infection and Immunity.

Immunomodulation by zwitterionic polysaccharides

D. Kasper, R. McLoughlin, 2010 .

Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.

J. Bartlett, D. Kasper, A. Onderdonk, 1977, The Journal of infectious diseases.

Bacteroides fragilis-stimulated interleukin-10 contains expanding disease.

D. Kasper, Jerry C. Lee, R. McLoughlin, 2011, The Journal of infectious diseases.

Virulence factors in infections with bacteroides fragilis: isolation and characterization of capsular polysaccharide and lipopolysaccharide.

A. Weintraub, D. Kasper, A. Lindberg, 1982, Scandinavian journal of infectious diseases. Supplementum.

Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701.

J. Bartlett, D. Kasper, A. Onderdonk, 2004, The Journal of infectious diseases.

Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease.

D. Kasper, P. Rice, W. Mccormack, 1980, Journal of immunology.

Analysis of a Capsular Polysaccharide Biosynthesis Locus of Bacteroides fragilis

D. Kasper, A. Pantosti, A. Tzianabos, 1999, Infection and Immunity.

Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci

D. Kasper, M. Pangburn, M. Wessels, 1992, Infection and immunity.

A Defined O-Antigen Polysaccharide Mutant of Francisella tularensis Live Vaccine Strain Has Attenuated Virulence while Retaining Its Protective Capacity

D. Kasper, E. Rubin, A. Tzianabos, 2007, Infection and Immunity.

The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides.

J. Brisson, D. Kasper, A. Pantosti, 1992, The Journal of biological chemistry.

Identification of a subspecies-specific capsular antigen from Bacteroides melaninogenicus subspecies asaccharolyticus by immunofluorescence and electron microscopy.

D. Kasper, B. Mansheim, C. A. Solstad, 1978, The Journal of infectious diseases.

Harrisons principles of internal medicine - 15th edition

Stephen L. Hauser, Anthony S. Fauci, J. Larry Jameson, 2001 .

Isolation and Chemical Characterization of a Capsular Polysaccharide Antigen Shared by Clinical Isolates ofEnterococcus faecalis and Vancomycin-ResistantEnterococcus faecium

D. Kasper, D. Goldmann, G. Pier, 1999, Infection and Immunity.

Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.

D. Kasper, C. Baker, M. Rench, 1990, The New England journal of medicine.

Immunochemical and Biological Characterization of Three Capsular Polysaccharides from a Single Bacteroides fragilisStrain

D. Kasper, A. Tzianabos, L. Comstock, 2001, Infection and Immunity.

Comprar Harrison's Principles of Internal Medicine. 18th Ed. 2 Volúmenes | Dennis Kasper | 9780071748896 | Mcgraw-Hill Education

Anthony S. Fauci, A. Fauci, D. Kasper, 2011 .

Purification and immunochemical characterization of the outer membrane complex of Bacteroides melaninogenicus subspecies asaccharolyticus.

D. Kasper, B. Mansheim, 1977, The Journal of infectious diseases.

Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination.

D. Kasper, C. Baker, M. Edwards, 1979, The Journal of pediatrics.

Legionella pneumophila: growth inhibition by human pharyngeal flora.

D. Kasper, E. Mason, P. Modern, 1980, The Journal of infectious diseases.

Comprar Harrison's Manual of Medicine | Dennis Kasper | 9780071477437 | Mcgraw-Hill Education

E. Braunwald, A. Fauci, D. Kasper, 2009 .

Class specificity of naturally acquired and vaccine-induced antibody to type III group B streptococcal capsular polysaccharide: determination with a radioimmunoprecipitin assay

D. Kasper, C. Baker, M. Edwards, 1984, Infection and immunity.

Carbohydrates and T cells: a sweet twosome.

D. Kasper, F. Avci, Xiangming Li, 2013, Seminars in immunology.

Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.

D. Kasper, G. Mandell, B. H. Wade, 1983, Journal of Antimicrobial Chemotherapy.

5 – Role of Bacterial Virulence Factors in Pathogenesis of Anaerobic Infections

D. Kasper, D. Zaleznik, 1989 .

Isolation of a C (Ibc) protein from group B Streptococcus which elicits mouse protective antibody.

D. Kasper, M. Valtonen, N. J. Levy, 1986, Microbial pathogenesis.

Approach to the Acutely Ill Infected Febrile Patient Approach to the Acutely Ill Infected Febrile Patient

D. Kasper, T. Barlam, 2015 .

Edward Harold Kass, MD, PhD

D. Kasper, 1996 .

Immune mechanisms in the prevention of intra-abdominal abscess formation.

D. Kasper, A. Onderdonk, J. Crabb, 1989, Scandinavian Journal of Infectious Diseases. Supplementum.

A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.

D. Ferris, D. Kasper, L. Meyn, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Correct structure of repeating unit of group B Streptococcus type III capsular polysaccharide.

D. Kasper, M. Wessels, 1990, The Journal of infectious diseases.

Kdo Hydrolase Is Required for Francisella tularensis Virulence and Evasion of TLR2-Mediated Innate Immunity

D. Kasper, N. Okan, Tae-Hyun Kim, 2013, mBio.

Sequence of the toxic shock syndrome toxin gene (tstH) borne by strains of Staphylococcus aureus isolated from patients with Kawasaki syndrome

D. Kasper, R. Deresiewicz, J. Flaxenburg, 1996, Infection and immunity.

A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease

D. Kasper, S. Dasgupta, D. Kasper, 2010, Mucosal Immunology.

Immunogenicity of polysaccharides from type III, group B Streptococcus.

D. Kasper, C. Baker, M. Edwards, 1978, The Journal of clinical investigation.

Mutations affecting the activity of toxic shock syndrome toxin-1.

D. Kasper, R. Finberg, J. Woo, 1994, Biochemistry.

Harrison's Principles of Internal Medicine 16th Edition

E. Braunwald, D. Kasper, Stephen. L. Hauser, 2004 .

Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen

H. Tettelin, R. Rappuoli, D. Kasper, 2005, Science.

An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System

S. Mazmanian, D. Kasper, C. Liu, 2005, Cell.

Orientations of the Bacteroides fragilis Capsular Polysaccharide Biosynthesis Locus Promoters during Symbiosis and Infection

D. Kasper, L. Comstock, E. Troy, 2010, Journal of bacteriology.

Diagnosis of pancreatic infection.

D. Kasper, D. Zaleznik, 1988, Gastroenterology.

A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2

D. Kasper, D. Golenbock, A. Tzianabos, 2006, The Journal of experimental medicine.

Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR.

D. Kasper, B. Cobb, 2008, Glycobiology.